Xencor (XNCR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 12, 2025, at the Pasadena, California headquarters.
Stockholders of record as of April 15, 2025, are eligible to vote on key proposals.
Proxy materials are available online, with options to request paper or email copies.
Voting matters and shareholder proposals
Election of eight director nominees to serve until the next annual meeting.
Ratification of KPMG LLP as the independent registered public accounting firm for fiscal year ending December 31, 2025.
Approval of an amendment to the 2023 Equity Incentive Plan, increasing authorized shares by 3,000,000.
Advisory vote on executive compensation for named executive officers.
Provision to conduct any other business properly brought before the meeting.
Board of directors and corporate governance
Eight nominees listed for election to the board, including Dr. Bassil I. Dahiyat and Dr. Ellen G. Feigal.
Board recommends voting in favor of all director nominees and proposals.
Latest events from Xencor
- Lead oncology and immunology assets advance toward pivotal trials and broad commercialization.XNCR
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Advancing bispecific antibody programs in oncology and autoimmune diseases with pivotal trials ahead.XNCR
Leerink Global Healthcare Conference 202610 Mar 2026 - Pivotal studies and novel biologics in oncology and autoimmune diseases drive clinical momentum.XNCR
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Pipeline progress, improved financials, and extended royalty revenue outlook through 2028.XNCR
Q4 202525 Feb 2026 - Multiple clinical readouts and new trials in autoimmune and oncology set for 2025.XNCR
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Broadened pipeline targets IBD and autoimmune diseases, with pivotal clinical data expected in 2025-2026.XNCR
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026 - Key clinical updates and pipeline expansion in immunology and oncology signal strong innovation.XNCR
Cantor Global Healthcare Conference 202531 Dec 2025 - Advancing bispecific antibody programs in autoimmune and oncology with key data expected by 2026.XNCR
Piper Sandler 37th Annual Healthcare Conference3 Dec 2025 - Key votes include director elections, auditor change, equity plan expansion, and say-on-pay.XNCR
Proxy Filing2 Dec 2025